XML 10 R4.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Income Statement [Abstract]    
Net revenue $ 279,219 $ 123,923
Cost of revenue [1] 250,814 116,274
Gross profit 28,405 7,649
Operating expenses:    
Product development [1] 8,620 7,637
Sales and marketing [1] 4,144 3,124
General and administrative [1] 16,848 6,787
Operating loss (1,207) (9,899)
Interest income 14 166
Interest expense (124) (111)
Other (expense) income (98) 29
Loss before income taxes (1,415) (9,815)
Benefit from (provision for) income taxes 49 (750)
Net loss (1,366) (10,565)
Comprehensive loss:    
Net loss (1,366) (10,565)
Other comprehensive loss:    
Foreign currency translation adjustment 0 (2)
Comprehensive loss $ (1,366) $ (10,567)
Net loss per share, basic [2] $ (0.02) $ (0.19)
Net loss per share, diluted [2] $ (0.02) $ (0.19)
Weighted-average shares used in computing net loss per share, basic 55,823 54,470
Weighted-average shares used in computing net loss per share, diluted 55,823 54,470
[1] Cost of revenue and operating expenses include stock-based compensation expense as follows:

 

Cost of revenue

 

$

2,875

 

 

$

2,052

 

Product development

 

 

1,046

 

 

 

773

 

Sales and marketing

 

 

1,095

 

 

 

640

 

General and administrative

 

 

3,391

 

 

 

1,810

 
[2] Diluted net loss per share does not reflect any potential common stock relating to stock options, restricted stock units, or shares issuable related to the ESPP due to net losses incurred during the three months ended September 30, 2024 and 2023. The assumed issuance of any additional shares would be anti-dilutive.